Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Shilan Liu"'
Autor:
GuiLin Zeng, LiRong Zeng, Ying Wang, Zhi Cao, XiangHua Zeng, ZhiHong Xue, ShiLan Liu, YaMao Li, Lang He
Publikováno v:
Hereditas, Vol 161, Iss 1, Pp 1-12 (2024)
Abstract Objective Non-small cell lung cancer (NSCLC) patients undergoing chemotherapy and immunotherapy experience disturbances in the gut microbiota. This study intends to find out the correlation between gut microbiota and clinical indices before
Externí odkaz:
https://doaj.org/article/d6f14838b19e47ae830bc957e2ca9478
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-7 (2024)
Abstract Background As a newly approved immune checkpoint inhibitor in China, serplulimab has been widely used in the immunotherapy of tumors. However, the immune-related adverse events of immune checkpoint inhibitors should not be ignored. Although
Externí odkaz:
https://doaj.org/article/7c3b24c3c40e494eb255417741d03cfa
Autor:
Shilan Liu, Xiao Liu, Ting Wang, Chunhua Zeng, Baichen Ren, Xiaodan Yu, Min Xu, Wenjuan Li, Zhihui Qiao, Chuanyun You, Qinghui Yang, Mei Chen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Choroidal metastasis as an initial presenting feature of lung cancer with EML4-ALK translocation is exceedingly rare and greatly impacts patient quality of life (QOL). There are no recommended treatments for such patients, and palliative care remains
Externí odkaz:
https://doaj.org/article/b38fcaa25e5d4d09bc0eb60ef2dda455
Autor:
Fengyou Yao1, Shilan Liu2, Qian Yu1, Luyong Huang1, Denghong Zhang2, Yong Li1, Mingjian Lang3, Jingjing Hu3 345889568@qq.com
Publikováno v:
Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi. Aug2022, Vol. 26 Issue 8, p665-667. 3p.
Publikováno v:
Third International Conference on Computer Science and Communication Technology (ICCSCT 2022).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b245e76049ba50ae5494add9cf250d4d
https://doi.org/10.1117/12.2662876
https://doi.org/10.1117/12.2662876
Publikováno v:
Cancer Research. 82:3593-3593
Introduction: Chemotherapy-induced diarrhea (CID) is a common and potentially life-threatening side effect of chemotherapy and has an incidence of 50% - 80% with 5FU and irinotecan (CPT-11). For severe CID, dose reduction, interruption, or discontinu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43d384f026f1ac74b0dc7bf8f3e50c4c
https://doi.org/10.1158/1538-7445.am2022-3593
https://doi.org/10.1158/1538-7445.am2022-3593
Publikováno v:
Journal of Clinical Oncology. 40:e24085-e24085
e24085 Background: Chemotherapy-induced diarrhea (CID) is a potentially life-threatening AE (incidence 50-80% with 5FU/irinotecan). Chemotherapy dose reduction or discontinuation is often required. Cyclin-dependent kinases 4/6 (CDK4/6) regulate cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbb60408b8e15e2b13d86af4700321ca
https://doi.org/10.1200/jco.2022.40.16_suppl.e24085
https://doi.org/10.1200/jco.2022.40.16_suppl.e24085
Autor:
Minhong Wu, Cailing Liu, Shilan Liu, Hongyong Gu, Zhiling Yu, Pengxiu Lin, Lanzhen Tu, Qingsheng Chen
Publikováno v:
Minerva urology and nephrology. 73(2)
INTRODUCTION We reviewed current studies and performed a meta-analysis to compare outcomes between laparoscopic partial nephrectomy (LPN) and robot-assisted partial nephrectomy (RAPN) treating complex renal tumors (RENAL score ≥7 or maximum clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d52b725795bd7eb5c925f225a99a9403
https://pubmed.ncbi.nlm.nih.gov/33439576
https://pubmed.ncbi.nlm.nih.gov/33439576
Autor:
Deodial Guiadeen, Shilan Liu, Jian Liu, Charles G. Garlisi, Arto D. Krikorian, Ronald M. Kim, Ying-Duo Gao, Peter Stivers, Hugh Y. Zhu, Alan B. Cooper, Rajan Anand, Philip E. Brandish, Younong Yu, Nathan Bays, Jiaqiang Cai, Ian Knemeyer, Erica Leccese, Zangwei Xu, Kevin M. Maloney, Alexandra Hicks, Sobhana Babu Boga, Chundao Yang, Joseph A. Kozlowski, My Sam Mansueto, Hao Wu, Thierry O. Fischmann, Desai Jagdish A, Jeremy Presland, Abdul-Basit Alhassan, Xiaolei Gao, Wang James J-S
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 27:3939-3943
8-Amino-imidazo[1,5- a ]pyrazine-based Bruton’s tyrosine kinase (BTK) inhibitors, such as 6 , exhibited potent inhibition of BTK but required improvements in both kinase and hERG selectivity (Liu et al., 2016; Gao et al., 2017). In an effort to mai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::374dfa7e3c822671c1df7ad53a01c129
https://doi.org/10.1016/j.bmcl.2017.03.040
https://doi.org/10.1016/j.bmcl.2017.03.040
Autor:
Pengxiu LIN, Minhong WU, Hongyong GU, Lanzhen TU, Shilan LIU, Zhiling YU, Qingsheng CHEN, Cailing LIU
Publikováno v:
Minerva Urologica e Nefrologica; Apr2021, Vol. 73 Issue 2, p154-164, 11p